Ignite Creation Date:
2025-12-25 @ 3:49 AM
Ignite Modification Date:
2026-02-25 @ 4:49 PM
Study NCT ID:
NCT02013102
Status:
UNKNOWN
Last Update Posted:
2013-12-17
First Post:
2013-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome
Sponsor:
Cttq
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DREAM-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None